Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001410578-24-001704
Filing Date
2024-10-29
Accepted
2024-10-29 16:56:18
Documents
87
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A clrb-20231231x10ka.htm   iXBRL 10-K/A 5814706
2 EX-21.1 clrb-20231231xex21d1.htm EX-21.1 3158
3 EX-23.1 clrb-20231231xex23d1.htm EX-23.1 3865
4 EX-31.1 clrb-20231231xex31d1.htm EX-31.1 11669
5 EX-31.2 clrb-20231231xex31d2.htm EX-31.2 11652
6 EX-32.1 clrb-20231231xex32d1.htm EX-32.1 5959
  Complete submission text file 0001410578-24-001704.txt   27038651

Data Files

Seq Description Document Type Size
7 EX-101.SCH clrb-20231231.xsd EX-101.SCH 61014
8 EX-101.CAL clrb-20231231_cal.xml EX-101.CAL 51261
9 EX-101.DEF clrb-20231231_def.xml EX-101.DEF 373093
10 EX-101.LAB clrb-20231231_lab.xml EX-101.LAB 429303
11 EX-101.PRE clrb-20231231_pre.xml EX-101.PRE 562863
90 EXTRACTED XBRL INSTANCE DOCUMENT clrb-20231231x10ka_htm.xml XML 8485682
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36598 | Film No.: 241406478
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)